Advertisement

A 47-year-old woman with progressive numbness and weakness in the limbs

  • Lingchao Meng
  • Yun Yuan
  • Shan Chen
Chapter

Abstract

We present a case of toxic polyneuropathy induced by the exposure to leather cements in shoe industries. A nerve biopsy showed the presence of “giant axons” similar to hereditary giant axonal neuropathy (GAN) caused by recessive mutations in the GAN gene encoding gigaxonin. Similar case reports in the literature suggest that it is due to chronic intoxication of n-hexane found in the cements used in the shoe manufacturing process. The neuropathy symptoms in our patient significantly improved after discontinuing the exposure.

Keywords

N-hexane Giant axonal neuropathy Sural nerve biopsy 

References

  1. 1.
    Rizzuto N, Terzian H, Galiazzo-Rizzuto S. Toxic polyneuropathies in Italy due to leather cement poisoning in shoe industries. A light- and electron-microscopic study. J Neurol Sci. 1977;31(3):343–54.CrossRefGoogle Scholar
  2. 2.
    Chang CM, Yu CW, Fong KY, Leung SY, Tsin TW, Yu YL, Cheung TF, Chan SY. N-hexane neuropathy in offset printers. J Neurol Neurosurg Psychiatry. 1993;56(5):538–42.CrossRefGoogle Scholar
  3. 3.
    Smith AG, Albers JW. n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve. 1997;20(11):1445–50.CrossRefGoogle Scholar
  4. 4.
    Neghab M, Soleimani E, Khamoushian K. Electrophysiological studies of shoemakers exposed to sub-TLV levels of n-hexane. J Occup Health. 2012;54(5):376–82.CrossRefGoogle Scholar
  5. 5.
    Misirli H, Domaç FM, Somay G, Araal O, Ozer B, Adigüzel T. N-hexane induced polyneuropathy: a clinical and electrophysiological follow up. Electromyogr Clin Neurophysiol. 2008;48(2):103–8.PubMedGoogle Scholar
  6. 6.
    Chang AP, England JD, Garcia CA, Sumner AJ. Focal conduction block in n-hexane polyneuropathy. Muscle Nerve. 1998;21(7):964–9.CrossRefGoogle Scholar
  7. 7.
    Israeli E, Dryanovski DI, Schumacker PT, Chandel NS, Singer JD, Julien JP, et al. Intermediate filament aggregates cause mitochondrial dysmotility and increase energy demands in giant axonal neuropathy. Hum Mol Genet. 2016;25(11):2143–57.CrossRefGoogle Scholar
  8. 8.
    LoPachin RM, Lehning EJ. The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper. Neurotoxicology. 1997;18(1):7–22.PubMedGoogle Scholar
  9. 9.
    Spencer PS, Schaumburg HH. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol. 1977;36(2):276–99.CrossRefGoogle Scholar
  10. 10.
    Wang L, Zhao D, Wang Z, Zhang W, Lv H, Liu X, et al. Heterogeneity of axonal pathology in Chinese patients with giant axonal neuropathy. Muscle Nerve. 2014;50(2):200–5.CrossRefGoogle Scholar
  11. 11.
    Hentati F, Hentati E, Amouri R. Giant axonal neuropathy. Handb Clin Neurol. 2013;115:933–8. ReviewCrossRefGoogle Scholar
  12. 12.
    Johnson-Kerner BL, Roth L, Greene JP, Wichterle H, Sproule DM. Giant axonal neuropathy: An updated perspective on its pathology and pathogenesis. Muscle Nerve. 2014;50(4):467–76.CrossRefGoogle Scholar
  13. 13.
    Bomont P. Degradation of the intermediate filament family by gigaxonin. Methods Enzymol. 2016;569:215–31.CrossRefGoogle Scholar
  14. 14.
    Graham DG, Anthony DC, Szakál-Quin G, Gottfried MR, Boekelheide K. Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy. Neurotoxicology. 1985;6(4):55–63.PubMedGoogle Scholar
  15. 15.
    Huang CC. Polyneuropathy induced by n-hexane intoxication in Taiwan. Acta Neurol Taiwan. 2008;17(1):3–10.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Lingchao Meng
    • 1
  • Yun Yuan
    • 1
  • Shan Chen
    • 2
  1. 1.Neuromuscular Division, Department of NeurologyPeking University First HospitalBeijingChina
  2. 2.Peripheral Neuropathy CenterRutgers University, Robert Wood Johnson Medical SchoolNew BrunswickUSA

Personalised recommendations